person

Miloslav K.

Country
Czechia
Department
Clinic

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 37 partner sites.

Specializations

Depressive Disorders

Investigator concentrates on Major Depressive Disorder and its resistant forms, exploring adjunctive and rapid‑acting treatments.

  • Adjunctive therapy to SSRIs/SNRIs
  • Rapid‑acting psychedelics
  • Long‑term safety of novel agents

Research includes patients with comorbid medical conditions and those unresponsive to standard antidepressants.

Schizophrenia and Psychosis

Focus on Schizophrenia, particularly Treatment‑Resistant Schizophrenia and associated cognitive deficits.

  • Adjunctive antipsychotic modulators
  • Safety profiling after prior trial exposure
  • Impact on positive and negative symptom scales

Emphasis on patients with persistent symptoms despite conventional therapy.

Neurodegenerative and Movement Disorders

Research spans ALS, Multiple Sclerosis, and atypical Parkinsonian syndromes such as Multiple System Atrophy, Progressive Supranuclear Palsy and Corticobasal Syndrome.

  • Depression management in neurodegenerative disease
  • Evaluating psychotropic safety in progressive disorders
  • Integrating neurological and psychiatric outcomes

Studies address psychological distress accompanying neuro‑motor decline.

Respiratory Chronic Illness

Targeted investigations involve Chronic Obstructive Pulmonary Disease and its psychiatric comorbidities.

  • Adjunctive antidepressant strategies
  • Assessment of mood improvement alongside pulmonary care
  • Safety of psychotropic agents in compromised respiratory function

Goal is to enhance quality of life for patients with chronic lung disease.

Women’s Health – Menopause

Dedicated to Sleep Disturbances linked to Menopause, evaluating novel therapeutics.

  • Mechanistic studies of sleep regulation
  • Safety and tolerability in post‑menopausal women
  • Objective sleep metrics (PSG) outcomes

Research aims to alleviate nocturnal symptoms affecting hormonal transition.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.